
    
      This was an open-label, vaccine study of Eastern Equine Encephalitis Vaccine, Inactivated
      Dried, EEE, TSI-GSD 104 in healthy, adult subjects. No concurrent control group was used. The
      controls used in this study to assess immunogenicity were historical PRNT80 values obtained
      in past studies of the EEE vaccine. Rates of adverse events (AEs) were tabulated by
      relationship to product administration and severity.

      The primary objectives are to assess the safety of Eastern Equine Encephalitis Vaccine,
      Inactivated, Dried EEE, TSI GSD 104, and to assess immunogenicity of Eastern Equine
      Encephalitis Vaccine, Inactivated, Dried EEE, TSI GSD 104.
    
  